Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate

Journal of Urology

Volumn 189, Issue 3, 2013, Pages 911-915

  Kehinde, Elijah O ^a   Al Maghrebi, May ^a   Sheikh, Mehraj ^a   Anim, Jehoram T ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

antibiotic prophylaxis; biopsy; ciprofloxacin; prostate; sepsis

Indexed keywords

AMIKACIN; CEFTRIAXONE; CIPROFLOXACIN; MEROPENEM; QUINOLONE DERIVATIVE; STEROID;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CHILL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEVER; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION RISK; KLEBSIELLA; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATITIS; SEPTICEMIA; SINGLE DRUG DOSE; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS;

AGED; AGED, 80 AND OVER; AMIKACIN; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOPSY, NEEDLE; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; RECTUM; SEPSIS; TREATMENT OUTCOME;

EID: 84873707321     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.08.237     Document Type: Article

References (28)

1. R. Raaijmakers, W.J. Kirkels, M.J. Roobol Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program Urology 60 2002 826
2. S. Loeb, H.B. Carter, S. Berndt Complications of prostate biopsy: data from SEER-Medicare J Urol 186 2011 1830
3. B. Challacombe, P. Dasgupta, U. Patel Recognizing and managing the complications of prostate biopsy BJU Int 108 2011 1233
4. D.A. Kapoor, I.W. Klimberg, G.H. Malek Single dose oral ciprofloxacin versus placebo for prophylaxis during transrectal controlled study Urology 52 1998 552
5. J.S. Wolf Jr, C.J. Bennett, R.R. Dmochowski Best practice policy statement on urologic surgery antimicrobial prophylaxis J Urol 179 2008 1379
6. M. Aron, T.P. Rajeev, N.P. Gupta Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study BJU Int 85 2000 682
7. S. Binsaleh, M. Al-Assiri, S. Aronson Septic shock after transrectal ultrasound guided prostate biopsy Is ciprofloxacin prophylaxis always protecting? Can J Urol 11 2004 2352
8. M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study 1998-2007 J Antimicrob Chemother 64 2009 169
9. G. Peralta, M.B. Sanchez, J.C. Garrido Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia J Anticrob Chemother 60 2007 855
10. K.B. Laupland, D.B. Gregson, D.L. Church Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region Clin Microbiol Infect 14 2008 1041
11. J. Feliciano, E. Teper, M. Ferrandino The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol 179 2008 952
12. T. Goto, S. Makinose, Y. Ohi Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate Int J Urol 5 1998 243
13. S. Nys, I.N. Okeke, S. Kariuki Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries J Antimicrob Chemother 54 2004 952
14. D. Batura, G.G. Rao, P.B. Nielson Adding amikacin to fluoroquinolone- based antimicrobial prophylaxis reduces prostate biopsy infection rates BJU Int 107 2011 760
15. Health Protection Agency Antimicrobial Resistance and Prescribing in England, Wales and Northern Ireland, 2008 www.hpa.org.uk/Publications/ InfectiousDiseases/Antimicrobia/AndHealthcareAssociatedInfections/ 0807Antimicrobialresistance2008/ Accessed April 2011
16. E.O. Kehinde, M. Sheikh, O.A. Mojiminiyi Higher serum prostate specific antigen levels in the absence of prostate cancer in Middle Eastern men The clinicians' dilemma BJU Int 91 2003 618
17. J.T. Anim, E.O. Kehinde, A. Prasad Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men Int Urol Nephrol 38 2006 27
18. M. Grabe, T.E. Bjerklund-Johansen, H. Botto Guidelines on Urological Infections 2011 European Association of Urology Arnhem, The Netherlands 78 93
19. S. Loeb, S. Van den Heurel, Z. Chu Infectious complications and hospital admissions after prostate biopsy in a European randomized trial Eur Urol 61 2012 1110
20. Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis (Updated February 2012) www.auanet.org/content/clinical-practice- guidelines.cfm Accessed July 2012
21. E.O. Kehinde, M. Sheikh, J. Anim Addition of single dose amikacin to prophylactic quinolones significantly reduces infectious complications of transrectal ultrasound guided biopsy of the prostate gland abstract 2084 J Urol 179 suppl. 2008 717
22. E. Kehinde, M. Abdel-Hamid, O. Philips A comparative pharmacokinetic study of seven brands of ciprofloxacin in NZW rabbits using liquid chromatography mass spectrometry technique abstract 811 J Urol 183 suppl. 2010 e316
23. M.E. Abdel-Hamid, L.H. Sharaf, O.A. Philips A rapid liquid chromatography-tandem mass spectrometry method for the determination of ciprofloxacin in rabbits serum following intragastric dosing: application to pharmacokinetics study Research J Pharm and Tech 5 2012 624
24. D. Batura, G.G. Rao, P.B. Nielsen Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy BJU Int 106 2010 1017
25. M.A. Liss, A. Chang, R. Santos Prevalence and significance of fluoroquinolone resistant Eschericia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy J Urol 185 2011 1283
26. C.A. Duplessis, M. Bavaro, M.P. Simons Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates Urology 79 2012 556
27. M.S. Pearle Should we change our prophylactic antimicrobial regimen for prostate biopsy? J Urol 185 2011 1181
28. S.A. Kaplan, D.E. Chung, J.S. Sandhu Generic substitutes are neither as safe nor effective as branded medications: experience in men treated for lower urinary tract symptoms (LUTS) abstract 1799 J Urol 181 suppl. 2009 649